Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
ANNUAL INCOME RANGE
BANK MODIFICATION
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Aspira Pathlab & Diagnostics Ltd
Industry : Healthcare
BSE Code
ISIN Demat
Book Value(
)
540788
INE500C01017
10.8004469
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
N.A
100.21
84.58
EPS(TTM)
Face Value(
)
Div & Yield %:
0.82
10
0
Back
Cil Securities Ltd
Cil Securities standalone net profit rises 35.14% in the June 2024 quarter
Aug 12,2024
Net profit of Cil Securities rose 35.14% to Rs 0.50 crore in the quarter ended June 2024 as against Rs 0.37 crore during the previous quarter ended June 2023. Sales rose 25.62% to Rs 2.55 crore in the quarter ended June 2024 as against Rs 2.03 crore during the previous quarter ended June 2023.
Particulars
Quarter Ended
Jun. 2024
Jun. 2023
% Var.
Sales
2.55
2.03
26
OPM %
30.59
26.11
-
PBDT
0.75
0.51
47
PBT
0.67
0.49
37
NP
0.50
0.37
35